Pfizer Net Income From Continuing Ops from 2010 to 2026
| PFE Stock | 12.00 0.02 0.17% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 7.2 B | Current Value 11.3 B | Quarterly Volatility 6.5 B |
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Interest Income of 485.3 M, Discontinued Operations of 5.1 M or Interest Expense of 1.9 B, as well as many indicators such as . Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
Pfizer | Net Income From Continuing Ops |
Evaluating Pfizer's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Pfizer Inc CDR's fundamental strength.
Latest Pfizer's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Pfizer Inc CDR over the last few years. It is Pfizer's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Pfizer Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 12,148,547,059 | |
| Geometric Mean | 10,696,459,596 | |
| Coefficient Of Variation | 53.27 | |
| Mean Deviation | 3,966,159,862 | |
| Median | 11,179,000,000 | |
| Standard Deviation | 6,471,416,918 | |
| Sample Variance | 41879236.9T | |
| Range | 29.2B | |
| R-Value | 0.04 | |
| Mean Square Error | 44599842.6T | |
| R-Squared | 0 | |
| Significance | 0.88 | |
| Slope | 51,214,461 | |
| Total Sum of Squares | 670067790.9T |
Pfizer Net Income From Continuing Ops History
About Pfizer Financial Statements
Pfizer investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Pfizer Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 7.2 B | 11.3 B |
Pair Trading with Pfizer
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pfizer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will appreciate offsetting losses from the drop in the long position's value.Moving together with Pfizer Stock
Moving against Pfizer Stock
| 0.71 | MSG | Mithril Silver | PairCorr |
| 0.56 | CMC | Cielo Waste Solutions | PairCorr |
| 0.47 | AUUA | Aluula Composites | PairCorr |
The ability to find closely correlated positions to Pfizer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pfizer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pfizer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pfizer Inc CDR to buy it.
The correlation of Pfizer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pfizer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pfizer Inc CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pfizer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.